ECM
HOLX

EagleClaw Capital Management’s Hologic HOLX Stock Holding History

EagleClaw Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,984
Closed -$2.42M – 149
2026
Q1 		$2.42M Sell
31,984
-1,848
-5% -$139K 0.34% 69
2025
Q4 		$2.52M Sell
33,832
-468
-1% -$34.2K 0.36% 69
2025
Q3 		$2.31M Sell
34,300
-1,650
-5% -$110K 0.32% 76
2025
Q2 		$2.34M Sell
35,950
-700
-2% -$42K 0.35% 73
2025
Q1 		$2.26M Hold
36,650
– – 0.36% 74
2024
Q4 		$2.64M Hold
36,650
– – 0.42% 66
2024
Q3 		$2.99M Hold
36,650
– – 0.5% 58
2024
Q2 		$2.72M Hold
36,650
– – 0.49% 59
2024
Q1 		$2.86M Hold
36,650
– – 0.52% 59
2023
Q4 		$2.62M Hold
36,650
– – 0.55% 57
2023
Q3 		$2.54M Sell
36,650
-250
-0.7% -$18.9K 0.58% 56
2023
Q2 		$2.99M Sell
36,900
-500
-1% -$40.9K 0.69% 52
2023
Q1 		$3.02M Sell
37,400
-650
-2% -$52.3K 0.71% 51
2022
Q4 		$2.85M Hold
38,050
– – 0.69% 53
2022
Q3 		$2.46M Sell
38,050
-600
-2% -$41.6K 0.69% 51
2022
Q2 		$2.68M Sell
38,650
-600
-2% -$44.5K 0.73% 47
2022
Q1 		$3.02M Sell
39,250
-2,700
-6% -$194K 0.69% 48
2021
Q4 		$3.21M Buy
41,950
+2,800
+7% +$206K 0.7% 43
2021
Q3 		$2.89M Buy
39,150
+675
+2% +$50.6K 0.75% 43
2021
Q2 		$2.57M Buy
38,475
+300
+0.8% +$20.1K 0.66% 48
2021
Q1 		$2.84M Sell
38,175
-400
-1% -$30.4K 0.82% 39
2020
Q4 		$2.81M Sell
38,575
-175
-0.5% -$12.4K 0.89% 32
2020
Q3 		$2.58M Hold
38,750
– – 0.9% 36
2020
Q2 		$2.21M Buy
38,750
+2,100
+6% +$103K 0.86% 41
2020
Q1 		$1.29M Hold
36,650
– – 0.61% 55
2019
Q4 		$1.91M Hold
36,650
– – 0.7% 47
2019
Q3 		$1.85M Sell
36,650
-250
-0.7% -$12.3K 0.75% 44
2019
Q2 		$1.77M Hold
36,900
– – 0.77% 42
2019
Q1 		$1.79M Sell
36,900
-1,950
-5% -$87.9K 0.82% 40
2018
Q4 		$1.59M Sell
38,850
-500
-1% -$20.5K 0.84% 42
2018
Q3 		$1.61M Sell
39,350
-500
-1% -$20.2K 0.7% 50
2018
Q2 		$1.59M Hold
39,850
– – 0.77% 44
2018
Q1 		$1.49M Sell
39,850
-50
-0.1% -$2.02K 0.75% 49
2017
Q4 		$1.71M Sell
39,900
-100
-0.3% -$3.99K 0.86% 44
2017
Q3 		$1.47M Sell
40,000
-350
-0.9% -$14.1K 0.83% 50
2017
Q2 		$1.83M Sell
40,350
-200
-0.5% -$8.83K 1.07% 30
2017
Q1 		$1.73M Sell
40,550
-1,050
-3% -$42.8K 1.04% 35
2016
Q4 		$1.66M Sell
41,600
-300
-0.7% -$11.6K 1.05% 37
2016
Q3 		$1.63M Sell
41,900
-100
-0.2% -$3.77K 1.04% 38
2016
Q2 		$1.46M Buy
42,000
+500
+1% +$17.3K 0.97% 39
2016
Q1 		$1.43M Hold
41,500
– – 0.97% 38
2015
Q4 		$1.6M Sell
41,500
-300
-0.7% -$11.7K 1.06% 34
2015
Q3 		$1.64M Sell
41,800
-1,350
-3% -$53.5K 1.15% 36
2015
Q2 		$1.64M Buy
43,150
+750
+2% +$26.3K 1.05% 39
2015
Q1 		$1.4M Buy
42,400
+2,400
+6% +$73.7K 0.91% 43
2014
Q4 		$1.07M Sell
40,000
-700
-2% -$18.1K 0.7% 53
2014
Q3 		$990K Sell
40,700
-900
-2% -$22.7K 0.67% 53
2014
Q2 		$1.05M Hold
41,600
– – 0.71% 51
2014
Q1 		$900K Buy
+41,600
New +$897K 0.65% 54

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EagleClaw Capital Management's HOLX Position: Q2 2026 in Review

EagleClaw Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 31,984 shares — an estimated $2.42M sold.

EagleClaw Capital Management first reported a position in HOLX in Q1 2014 and held it in 49 quarters. The position peaked at $3.21M in Q4 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • EagleClaw Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • EagleClaw Capital Management sold 31,984 Hologic shares in Q2 2026, an estimated $2.42M.
  • EagleClaw Capital Management first reported a position in Hologic in Q1 2014 and held it in 49 quarters.
  • EagleClaw Capital Management's Hologic position peaked at $3.21M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on EagleClaw Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.